Progenitor T cells drive chronic pulmonary type 2 inflammation
Abstract Type 2 inflammation unfolds over time and is coordinated by remarkably durable CD4+ Th2 cell responses, standing in contrast to the collapse of adaptive immunity seen in chronic infection and malignancy. In experimental models, short-lived Th2 effector cells and type 2 innate lymphocytes (ILC2) contribute to acute type 2 inflammation, yet the cellular architecture that drives chronic type 2 inflammation and prevents exhaustion remains poorly understood. To define the Th2 landscape in chronic type 2 inflammation, we established a mouse model of long-term pulmonary allergen exposure and found that type 2 inflammation was broadly sustained over at least 4 months despite chronic stimulation. Th2 cells in the lung parenchyma during chronic inflammation were distinct from acute inflammation and resting memory phases, and included an expanded T cell factor-1 (TCF1)-expressing progenitor-like Th2 population. Tissue Th2 progenitors were absent in the nose and in helminth infections, suggesting that type 2 immunopathology is context-specific. Transcriptomic deconstruction of acute and chronic pulmonary Th2 responses defined divergent effector programs as well as the transcriptional signature of a tissue Th2 memory population that resembled human Th2 progenitors. Integrated transcriptomic analysis comparing type 2 inflammation to chronic viral infection revealed a distinct stemness module underlying chronic Th2 inflammation that was separable from a common core memory module. In vivo , lung Th2 progenitors coupled self-renewal with effector cell differentiation and could be sustained for weeks without antigen persistence or contribution from the lymph node. Maintenance of Th2 progenitors was partially dependent on lung parenchymal B cells and associated with bronchus-associated lymphoid tissue formation. Moreover, Th2 progenitors, in contrast to Th2 effectors and ILC2s, were sufficient to both initiate and sustain type 2 inflammation. Thus, we define tissue Th2 progenitors as a distinct cellular state that arises during chronic type 2 inflammation and establish the central role of these cells in maintaining the architecture of Th2 responses over time.
Authors
- Caitlin Wong (ORCID: https://orcid.org/0000-0002-6807-7835)
- M. A. Bell
- Thornton W. Thompson (ORCID: https://orcid.org/0000-0002-6352-8238)
- Joshua A. Boyce (ORCID: https://orcid.org/0000-0002-2401-2351)
- Xiaojiong Jia (ORCID: https://orcid.org/0000-0001-9260-3498)
- Duane R. Wesemann (ORCID: https://orcid.org/0000-0002-6690-944X)
- Kinan Alhallak (ORCID: https://orcid.org/0000-0002-0512-0357)
- Jakob von Moltke (ORCID: https://orcid.org/0000-0003-2894-3353)
- Juying Lai (ORCID: https://orcid.org/0000-0002-2240-9806)
- Ersin Gül (ORCID: https://orcid.org/0000-0003-2873-8034)
- Alexander Perniss (ORCID: https://orcid.org/0000-0002-3143-4931)
- Radomir Kratchmarov (ORCID: https://orcid.org/0000-0002-6796-8564)
- Shahab Saghaei
- Lora Bankova
- Chunli Feng (ORCID: https://orcid.org/0000-0002-5048-9073)
- Jun Nagai (ORCID: https://orcid.org/0000-0003-4720-5065)
- Patrick J. Brennan (ORCID: https://orcid.org/0000-0003-0715-8209)
- Gaspar A. Pacheco
- Hiroaki Hayashi
- Madeline M. Hastings
Institutions
- Broad Institute (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University of Washington (US)
- Ragon Institute of MGH, MIT and Harvard (US)
Publication Details
- Journal
- Nature Immunology
- Published
- 2026-08-20
- DOI
- https://doi.org/10.1038/s41590-026-02619-y
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institute of Allergy and Infectious Diseases